期刊文献+

银杏叶提取物对2型糖尿病大鼠心肌保护机制的研究 被引量:3

Research on Myocardium Protection Mechanism of Ginkgo Biloba Extracts in Type 2 Diabetes Rats
下载PDF
导出
摘要 目的:研究银杏叶提取物对2型糖尿病大鼠脂代谢及心肌细胞PPARγmRNA表达的影响,探讨银杏叶提取物对2型糖尿病的治疗作用。方法:用高糖-高脂肪饲料刺激加小剂量链脲佐菌素(STZ)制备2型糖尿病大鼠模型,将空腹血糖>16.6mmol/L的20只大鼠随机分为糖尿病组(10只)和治疗组(10只),另设正常组(10只)。治疗组大鼠给予银杏叶提取物灌胃,糖尿病组和正常组给予0.9%氯化钠注射液灌胃。治疗10周后取血清测定血脂、空腹血糖(FBG)、血清胰岛素(INS),计算胰岛素抵抗指数(IRI);测定心肌组织丙二醛(MDA)、超氧化物岐化酶(SOD)含量;采用半定量逆转录-聚合酶链式反应(RT-PCR)检测正常组、糖尿病组和治疗组大鼠心肌细胞PPARγmRNA表达量。结果:与糖尿病组大鼠相比较,治疗组大鼠心肌组织PPARγmRNA表达量升高(P<0.05)、MDA降低(P<0.01)、SOD升高(P<0.01);而FBG、INS及IRI显著降低(P<0.05或P<0.01)。结论:银杏叶提取物能够明显降低2型糖尿病大鼠的高血糖,降低胰岛素抵抗水平,改善脂质过氧化状态,并且可以提高2型糖尿病大鼠心肌细胞PPARγmRNA的表达,对2型糖尿病有一定的治疗作用。 【Objective】To study effect of Ginkgo biloba extracts on lipid metabolism and the peroxisome proliferators activated receptorγmRNA(PPARγmRNA) expression of the myocardium cell in the experimental type 2 diabetes rats and therapeutic effect of Ginkgo biloba extracts on the type 2 diabetes.【Method】Diabetes rat models were induced by high glucose and high fat feedstuff and low-dosage streptozotocin.The rats were randomized into model group(10) and therapy group(10) whose fasting blood-glucose(FBG) is more than16.6 mmol/L.Normal control group(10) is set.The rats of therapy group were lavaged with Ginkgo biloba extracts,the other groups were lavaged with 0.9% NaCl.After 10 weeks,we detected blood lipoid,FBG,blood insulin(INS) for calculating insulin resistance index(IRI),the content of MDA and SOD.The content of PPARγmRNA expression all groups was detected by RT-PCR.【Result】The content of PPARγmRNA expression in therapy group was higher,MDA was decreased,SOD was increased,FBG,FINS and IRI were decreased compared with the model group.【Conclusion】Ginkgo biloba extracts could decrease the blood sugar and insulin resistance,improve lipid peroxidation,increase the content of PPARγmRNA expression of myocardium in type 2 diabetes rats.Ginkgo biloba extracts has therapeutic effect on type 2 diabetes.
出处 《中国食物与营养》 2011年第5期67-70,共4页 Food and Nutrition in China
基金 2009年黑龙江省卫生厅科研项目"银杏叶提取物对2型糖尿病大鼠心肌保护机制的研究"(项目编号:2009-408) 2008年牡丹江医学院科研项目"银杏叶提取物对实验性2型糖尿病大鼠心肌细胞钙通道基因表达的研究"(项目编号:B200806)
关键词 银杏叶提取物 2型糖尿病 胰岛素抵抗 过氧化物酶体增殖物激活受体Γ Ginkgo biloba extracts type 2 diabetes insulin resistance PPARγ
  • 相关文献

参考文献9

  • 1Maeda N, Takahashi M, Funahashi T, et al. PPAR gramma ligands increase expression and plasma concentrations of adiponectin, an adipose 2 derived protein. Diabetes, 2001, 50:2004.
  • 2Clostre F. Gingo biloba extract(EGb761):State of knowledge in the dawn of the year 2000. Ann Pharm Fr, 1999,57(1):80-88.
  • 3郭啸华,刘志红,李恒,黎磊石.高糖高脂饮食诱导的2型糖尿病大鼠模型及其肾病特点[J].中国糖尿病杂志,2002,10(5):290-294. 被引量:304
  • 4Ku D D. Sellers B M. Effect of streptozotocin diabetes and insulin treatment on myocardial sodium pump and contractility of the rat heart. J Pharmacol Exp Ther, 1992. 222:395.
  • 5InoueI, GotoS, MatsunagaT, et al. The ligands factivators for peroxisome proliferator-activated receptor alpha (PPARalpha) and PPARgamma increase Cu^+, Zn^2+ superoxide dismutase and decrease p22phox message expressions in primary endothelial cells. Metabolism, 2001,50(1):3-11.
  • 6MilesPD, BarakY, HeW, et al. Improved insulin sensitivity in mice heterozygous for PPARgamma deficiency. J Clin Invest, 2000,3:287.
  • 7Shimabukuro M, Higa S, Shirtzato T, et al. Cardiopretective effects of troglitazone in strcptozotoein-induced diabetie rats. Metabolism, 1996,45(9): 1168-1173.
  • 8Ahluwalia M, Evans M, Morris K, et al. The influence of the Prol2Ala mutation of the PPAR-gamma receptor gene on metabolic and clinical characteristics in treatmentnaive patients witll type 2 diabetes. Diabetes Obes Metab, 2002, 4 (6):376-378.
  • 9张新歌,李朝兴,张慧杰,汤宇,王瑱.选择性PPARγ调节剂治疗2型糖尿病的研究[J].药学进展,2005,29(12):550-556. 被引量:3

二级参考文献42

  • 1Lehmann J M,Moore L B,Smithlr-Oliver T A,et al.An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferators-activated receptor gamma(PPAR gamma)[J].J Biol Chem,1995,270(22):12953-12956.
  • 2Mukherjee R,Jow L,Crosten G E,et al.Identification,characterization and tissue distribution of human peroxisome proliferator-activated receptor (PPAR) isoforms PPARγ2 versus PPARγ1 and activation with retion X receptor agonists and antagonists[J].J Biol Chem,1997,272(12):8071-8076.
  • 3Fajas L,Fruchart J C,Auwerx J.PPARγ3 mRNA:a distinct moter[J].FEBS Lett,1998,438(1-2):55-60.
  • 4Olefsky J M,Saltiel A R.PPARγ and the treatment of insulin resistance[J].Trends Endocrinol Metab,2000,11(9):362-368.
  • 5Yamamoto Y,Nakajima M,Yamazaki H,et al.Cytotocity and apopotosis produced by troglitazone in human hepatoma cells[J].Life Sci,2002,70(4):471-482.
  • 6Motomura Wataru,Nagamine Miho,Tanno Satoshi,et al.Inhibition of cell invasion and morphological change by troglitazone in human pancreatic cancer cells[J].J Gastroenterol,2004,39(5):461-468.
  • 7Chilcott J,Tappenden P,Jones M L,et al.A systematic review of the clinical effectiveness of pioglitazone in the treatment of type 2 diabetes meilitus[J].Clin Ther,2001,23(11):1792-1823.
  • 8Junichi Sakamoto,Hiroyuki Kimura,Shinji Moriyama,et al.Activation of human peroxisome proliferator-activated receptor (PPAR) subtypes by pioglitazone[J].Biochem Biophys Res Commun,2000,278(3):704-711.
  • 9Malinowski J M,Bolesta S.Rosiglitazone in the treatment of type 2 diabetes mellitus:a critical review[J].Clin Ther,2000,22 (10):1151-1168.
  • 10Sheu S H,Kaya T,Waxman D J,et al.Exploring the binding site structure of the PPARγ ligand-binding bomain by computational solvent mapping[J].Biochemistry,2005,44(4):1193-1209.

共引文献305

同被引文献56

  • 1习雪峰,崔节荣,王勇.余甘子对胰岛素抵抗大鼠过氧化物酶体增生物激活受体γ表达的影响[J].食品科学,2009,30(5):253-256. 被引量:9
  • 2何新益,刘仲华.苦瓜多糖降血糖活性的高通量筛选研究[J].食品科学,2007,28(2):313-316. 被引量:29
  • 3刘毅,王文健,陈伟华,应健.黄芪多糖对3T3-L1前脂肪细胞增殖和分化的影响[J].中西医结合学报,2007,5(4):421-426. 被引量:40
  • 4刘芳芳,杨明炜,王晓强,王开富,陆付耳.梓醇与小檗碱及其配伍对胰岛素抵抗3T3-L1脂肪细胞的影响[J].中草药,2007,38(10):1523-1526. 被引量:16
  • 5Arredondo A. Diabetes: global challenge with high economic burden for public health systems and society [J]. Am J Public Health, 2013, 103 (2): e1-2.
  • 6Kearney MT. Changing the way we think about endothelial cell insulin sensitivity, nitric oxide, and the pathophysiology of type 2 diabetes: the FoxO is loose [J]. Diabetes, 2013, 62 (5): 1386-1388.
  • 7Zhang XJ, Deng YX, Shi QZ, et al. Hypolipidemic effect of the Chinese Polyherhal Huanglian Jiedu decoction in type 2 diabetic rats and its Possible mechanism [J]. Phytomedicine, 2013, Dec 21. [Epub ahead of Print].
  • 8Li JC, Shen XF, Meng XL. A traditional Chinese medicine JiuHuangLian (Rhizoma coptidis steamed with rice wine) reduces oxidative stress injury in type 2 diabetic rats [J]. Food Chem Toxicol, 2013, 59: 222-229.
  • 9Kim KS, Oh da H, Kim JY, et al. Taurine ameliorates hyperglycemia and dyslipidemia by reducing insulin resistance and leptin level in Otsuka Long-Evans Tokushima fatty (OLETF) rats with long-term diabetes [J]. Exp Mol Med, 2012, 44 (11): 665-673.
  • 10Zhang M, Lv XY, Li J, et al. The characterization of high- fat diet and multiple low-dose streptozotocin induced type 2 diabetes rat model [J]. Exp Diabetes Res, 2008, 2008: 704045.

引证文献3

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部